Cafepharma Today

February 7 2025 - Novo Nordisk plans new study for CagriSema, targets 2026 submission
Novo Nordisk plans new study for CagriSema, targets 2026 submission
Musk's team accesses Medicare, Medicaid records
Genentech eyes lupus market for Gazyva with positive Phase III data readout
Bain buys Japanese pharma Mitsubishi Tanabe for $3.4bn
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Not So Fast, Schering ... er, Merck ... er, Whoever You Are
Motley Fool
Thursday, May 21, 2009 - 6:33pm
tags:
Merck, Schering Plough, JNJ, Remicade
GlaxoSmithKline shareholders back executive pay reforms
Guardian,UK
Thursday, May 21, 2009 - 3:24pm
tags:
GSK, Pharma CEOs
Stem Cell Stocks Mixed on Heavy Volume Action
Yahoo/Indie Research
Thursday, May 21, 2009 - 3:21pm
tags:
stem cells, Neuralstem, Cytori, Aastrom
Celator Pharmaceuticals says Cephalon will examine its technology
Yahoo/AP
Thursday, May 21, 2009 - 3:20pm
tags:
Celator, Cephalon
JNJ: Don't Get Fooled by Dividend Plays
Seeking Alpha
Thursday, May 21, 2009 - 3:19pm
tags:
JNJ, dividends
Drug stocks lose ground; Vical rallies on vaccine news
Marketwatch
Thursday, May 21, 2009 - 11:41am
tags:
Vical, drug stocks
[video]Mad About Options: Like a Bull in a Hospital (Biogen)
Yahoo/TheStreet.com
Thursday, May 21, 2009 - 11:39am
tags:
Biogen Idec, options
Human Genome Sciences files for approval of ABthrax, designed to treat inhaled anthrax
Yahoo/AP
Thursday, May 21, 2009 - 11:38am
tags:
Human Genome Sciences, anthrax, FDA, ABthrax
Eli Lilly starts late-stage Alzheimer's drug tests
Yahoo/AP
Thursday, May 21, 2009 - 10:50am
tags:
Eli Lilly, drug trials, Alzheimer's disease, solanezumab
Oscient fends off new patent challenge
Bizjournals.com
Thursday, May 21, 2009 - 10:31am
tags:
Oscient, patents, Antara
Barclays analyst upgrades Biogen on Tysabri
Yahoo/AP
Thursday, May 21, 2009 - 10:25am
tags:
Biogen Idec, upgrades, Tysabri
Amylin Responds to Eastbourne Letter
Yahoo
Thursday, May 21, 2009 - 10:24am
tags:
Amylin
Nexavar approved in Japan for liver cancer
Yahoo/AP
Thursday, May 21, 2009 - 10:24am
tags:
Japan, Nexavar, liver cancer, Bayer, ONYX Pharmaceuticals
Notes from BIO: Vaccine Applications to FDA Booming
InVivo
Thursday, May 21, 2009 - 10:22am
tags:
BIO, vaccines
Dr. Reddy's To Reorganize Drug-Discovery Operations
NASDAQ.com
Thursday, May 21, 2009 - 10:21am
tags:
Dr Reddy's, drug discovery
Pfizer's Kindler on Health-Care Reform and the Wyeth Deal
Businessweek
Thursday, May 21, 2009 - 6:46am
tags:
Jeff Kindler, Pharma CEOs, Pfizer, Wyeth, healthcare reform
J&J arbitrating to pull out of valuable Remicade partnership as Merck buys Schering-Plough
Yahoo/AP
Thursday, May 21, 2009 - 6:46am
tags:
JNJ, Merck, partnerships, Remicade, Schering Plough
Court Grants AstraZeneca Preliminary Injunction Against Apotex in PULMICORT RESPULES Patent Litigation
Yahoo
Thursday, May 21, 2009 - 6:45am
tags:
AstraZeneca, generics, Pulmicort
Isis and Genzyme: Clinical Trial Positive, Stock Not So Much
Motley Fool
Thursday, May 21, 2009 - 6:43am
tags:
drug trials, Isis Pharmaceuticals, Genzyme, mipomersen
PhRMA Tries to Keep ‘Comparative Effectiveness’ in Check
WSJ Online
Wednesday, May 20, 2009 - 10:20am
tags:
PhRMA, comparative effectiveness

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Today’s Rare Disease Launches Require the Right Specialty Pharmacy Partner
Drug Channels
An Evaluation of "Deep Research" Performance
In the Pipeline
The Continuing NIH/NSF Crisis, Part II
In the Pipeline
Revised and Extended: What's Happening Inside the NIH and NSF
In the Pipeline
What's Happening Inside the NIH and NSF
In the Pipeline
Vertical Integration Redux: How Pharmaceutical Wholesalers Are Transforming the Buy-and-Bill Market (Video)
Drug Channels
Informa Connect's Access USA
Drug Channels
Fresh Asteroid, Getcher Fresh Asteroid Here
In the Pipeline
Unlocking AI’s Promise in Patient Support Programs
Drug Channels

Latest Jobs

Cell Therapy Navigator
Houston, Texas, 77002
Inizio Engage
Rapid Deployment Representative
Fort Worth, Texas, 76102
Inizio Engage
Rapid Deployment Representative
Charlotte, North Carolina, 28245
Inizio Engage
Oncology Key Account Manager
Newark, New Jersey, 07175
Inizio Engage
Cell Therapy Navigator
Little Rock, Arkansas, 72208
Inizio Engage
Territory Business Manager
Philadelphia, Pennsylvania, 19107
Inizio Engage
Business Development Representative
Las Vegas, Nevada, 89105
Professional Case Management
Oncology Key Account Manager
Atlanta, Georgia, 30383
Inizio Engage
Territory Manager, Surgical Pain - South Houston, TX
TX,
Avanos Medical
Neurology Account Manager- MD/DC/N VA (Remote)
Annapolis, Maryland, 21401
Jazz Pharmaceuticals
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information